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In silico analysis of potential structural and functional
significance of human breast cancer gene BRCA2
sequence variants found in 5’ untranslated region
Abstract
Background and Purpose: BRCA1 and BRCA2 are major hereditary
breast/ovarian cancer predisposing genes and their mutations increase the
risk of developing cancer. Genetic testing of these two genes is nowadays
commonly performed but almost half of found genetics alterations are de-
clared as variants of unknown clinical significance. Interpretation of these
unclassified variants is the major concern for BRCA genes. The aim of this
study is to investigate potential structural and functional significance of se-
quence variants found in 5’ untranslated region (UTR) of BRCA2 gene.
Materials and Methods: Consensus secondary structure of BRCA2 5’
UTR was built based on nucleotide sequences from four different species.
We collected all found human BRCA2 5’ UTR variants and explored their
potentials effects by folding human BRCA2 5’ UTR including one of each
variant, using consensus structure as a constraint. If constrained folding re-
sults in a structure that is very different from the consensus one, this may in-
dicate that this particular sequence variant could have potential functional
impact.
Results: Most of the sequence alterations are found near the 3’ end of 5’
UTR, what is in the vicinity of the translation initiation site. Four of them:
c.-26G>A, c.-26G>C, c.-26G>T and c.-12T>C most notably disturbed
consensus secondary structure by creating substructures with lower mini-
mum free energy, thus less stable.
Conclusions: As previously deduced in the case of variant c.-26G>A,
changes c.-26G>C, c.-26G>T and c.-12T>C could unstabilize the loop
at the vicinity of the translation start site, which could increase the effi-
ciency of the translation and thereby increase the expression of BRCA2. Ac-
cordingly, our study suggests this three BRCA2 5’ UTR sequence variants as
suitable candidates for further functional characterization and thus poten-
tially clinically significant.
INTRODUCTION
BRCA1 (breast cancer 1, early onset) and BRCA2 (breast cancer 2,
early onset) genes, located on chromosome 17q12-21 and 13q12-3, re-
spectively, are the major hereditary breast/ovarian cancer predis-
posing genes and their mutations increase the risk of developing
cancer (1, 2). It is assumed that germline mutations in the coding re-
gion of these two genes are responsible for familial breast/ovarian can-
cers while reduced expression of these genes (caused by various mecha-
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nisms such as methylation of the CpG islands within the
promoter region, allelic deletion of the gene locus and se-
quence alterations identified outside the coding region)
is frequently observed in sporadic breast/ovarian tumors
(3, 4).
BRCA2 gene is transcribed into an 11-kb mRNA that
has 27 encoding exons and is translated into 3418 amino
acids long protein that has been implicated in processes
essential for all cells, including proliferation, develop-
ment, DNA repair, transcription and centrosome dupli-
cation (5, 6). In addition to female and male breast can-
cer, mutations in the BRCA2 gene can lead to an in-
creased risk of ovarian, prostate, pancreatic, fallopian
tube cancer and melanomas (7). Mutations in the central
part of the gene have been associated with a higher risk of
ovarian cancer and a lower risk of prostate cancer than
mutations in other parts of the gene (8).
Genetic testing for BRCA2 sequence alterations is
nowadays commonly performed, more recently also in
Croatia (9). There are over 1800 BRCA2 genetic variants
recorded in the Breast Cancer Information Core (BIC)
database (10), of which almost half are declared as vari-
ants of unknown clinical significance. Interpretation of
these unclassified variants (UVs) is the major concern for
BRCA genes, especially for risk assessment in genetic
counseling (11). Additional difficulties for biological and
clinical interpretation present genetic variants that do
not change the amino acid composition of protein, like
variants found within 5’ and 3’ untranslated regions
(UTRs) of messenger RNA.
Untranslated regions are parts of the mature mRNA
located before the start codon (5’ UTR) and after the stop
codon (3’ UTR). They are transcribed with the coding
region but they are not translated. Several regulatory
roles have been assigned to the untranslated regions, in-
cluding mRNA’s localization and stability, and transla-
tional efficiency (12). These functions depend both on
the sequence and structure of the UTRs (12). There are a
growing number of disorders that are caused by changes
in the cis-regulatory sequences of the UTRs (13). For hu-
man BRCA1 5’ UTR it has been shown to play an impor-
tant role in regulating BRCA1 translational efficiency
(14) and two somatic point mutations in this region
(c.-3G>C and c.-2A>T), which have been identified in
a highly aggressive, sporadic breast tumors, dramatically
reduced transcript translatability (15, 16). The role of
BRCA2 5’ UTR in post-transcriptional regulation of pro-
tein translation efficiency is not yet known. Only for the
sequence variant c.-26G>A was experimentally shown
that it increases the expression level of BRCA2 gene and
presents risk or protection according to the genotype sta-
tus in the sporadic form of breast cancer (17). But the
functioning of that sequence variant at the molecular
level was deduced only by computational analysis.
In the growing world of protein non-coding RNAs
(ncRNAs) (18) computational methods and algorithms
provide significant advancement and alleviation in re-
search (19). In this study we tried to computationally an-
alyze potential significance of human BRCA2 5’ UTR
sequence variants. So far, only two studies have been
conducted in silico to investigate functional effects of
BRCA2 5’ UTR sequence alterations (20, 21), but they
only searched if the sequence variants change nucleotide
patterns of potential regulatory regions in BRCA2 5’
UTR. As it is known that the functioning of ncRNAs de-
pends both on nucleotide sequence and their secondary
structure (base pairing) (22), we tried by predicting con-
sensus secondary structure of 5’ UTR to find out if there
are substructures that have been conserved by evolution,
as it is far more likely that conserved structures are func-
tionally important. Then we analyzed potential func-
tional significance of sequence variants found within hu-
man 5’ UTR of BRCA2 gene, what could be expressed by
disruption of the consensus secondary structure. In es-
sence, secondary structure is the list of base pairs, de-
noted by ij for a pairing between the ith and jth nucleo-
tides, where i < j by convention (23). Elements of RNA
secondary structure can be seen on Figure 1. RNA heli-
ces normally contain 6 base pairing combinations: The
Watson-Crick pairs GC, CG, AU, UA, and the slightly
weaker wobble pairs GU and UG.
The main aim of this study was to find out if compu-
tational screening for 5’ UTR sequence variants with po-
tential structural and functional significance can be used
for narrowing a list of candidates for further (much more
laborious and expensive) experimental molecular char-
acterization.
MATERIALS AND METHODS
Sequences of BRCA2 5’ UTRs from different species
were collected from UTRdb (24), a curated database of 5’
and 3’ untranslated sequences of eukaryotic mRNAs de-
rived from several sources of primary data.
Human BRCA2 5’ UTR sequence variants were col-
lected from three public databases: Breast Cancer Infor-
470 Period biol, Vol 112, No 4, 2010.
P. Ozreti} et al. BRCA2 5’ UTR sequence variants
Figure 1. Elements of RNA secondary structure (base pairing). Each
loop has at least one base pair. A stem consists of two or more consecu-
tive stacks.
mation Core (BIC) (10), the biggest BRCA1 and BRCA2
sequence alterations database; dbSNP (25) and KConFab
(26). In this study we included all present variants, re-
gardless if they are found in patients or healthy controls.
We used UTRscan server (27) to search human BRCA2
5’ UTR sequence for any of the patterns collected in
UTRSite (24), a collection of experimentally validated
functional sequence patterns located in eukaryotic 5’ or
3’ mRNA UTRs, that are crucial for many aspects of gene
regulation and expression. If different BRCA2 5’ UTR
sequence of each UTR sequence variants is found to
have different functional pattern(s), this UTR sequence
variant could have functional significance.
Structural analysis of BRCA2 5’ UTR and its se-
quence variants was performed using different tools from
the Vienna RNA websuite (28). There are two main
computational approaches for predicting RNA secondary
structure: the first is a thermodynamic method, which
assumes that a given sequence will fold into the structure
with the minimum free energy (MFE) (29) and the sec-
ond approach compares multiple orthologous sequences
to identify patterns of co-evolution between sites that
could be indicative of compensatory mutations (30) to
maintain complementary base pairing within stacked
base pairs (31, 32). Since the accuracy of thermodynamic
secondary structure predictions for individual sequences
is rather limited, computing the consensus structure com-
mon to several related RNA sequences can drastically
improve the prediction (33). Consensus secondary struc-
ture of BRCA2 5’ UTR was predicted using RNAalifold
web server (34). RNAalifold works like single sequence
folding algorithms with the main difference being the
energy model is augmented by covariance information.
Compensatory mutations (e.g., a UA pair mutates to a
CG pair) and consistent mutations (e.g., AU mutates to
G×U) give a »bonus« energy, whereas inconsistent muta-
tions (e.g., C×G mutates to C A) yield a penalty. This re-
sults in a consensus MFE structure common to most of
the sequences in an alignment (34). Multiple sequence
alignment, prerequisite for consensus structure predic-
tion, was constructed using ClustalX2 version 2.0.12
software (35). To explore potentials effects of human
BRCA2 5’ UTR sequence variants on consensus 5’ UTR
secondary structure, folding of human BRCA2 5’ UTR
including one of each variant was predicted with RNAfold
(28) using consensus structure as a constraint. If con-
strained folding results in a structure that is very different
from the consensus one, this may indicate that this par-
ticular sequence variant could have potential impact on
normal BRCA2 5’ UTR.
RESULTS
We retrieved nine different BRCA2 5’ UTR sequences
from eight species (mouse has two different BRCA2 5’
UTR transcripts) and according to the sequence identity
and length, four BRCA2 5’ UTR sequences were in-
cluded in further analysis: human (Homo sapiens, 227
nucleotides, accession nr. BR431031), chimpanzee (Pan
troglodytes, 212 nt, BR307535), rhesus monkey (Macaca
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Figure 2. Structure annotated alignment. Consensus secondary structure of BRCA2 5’ UTR based on alignment of sequences from four different spe-
cies is presented in the first line in dot-bracket notation. Gray bars under the multiple sequence alignment present level of base conservation within
that position in four 5’ UTR sequences. The colors of the shadings indicate the number of different types of letter combinations that form a base pair.
Red means that there is 1 and ochre that there are 2 different base-pair combinations. If a base pair cannot be formed in one or more sequences, the
colors are shown faded in different levels.
mulatta, 212 nt, BR134108) and dog (Canis lupus fa-
miliaris, 208 nt, BR118937).
We found thirteen different human BRCA2 5’ UTR
variants: c.-175C>T, c.-123G>T, c.-52A>G, c.-34T>C,
c.-26G>A, c.-26G>C, c.-26G>T, c.-15A>C, c.-14T>C,
c.-12T>C, c.-12T>G, c.-11C>T and c.-9T>C.
According to UTRscan, human wild-type BRCA2 5’
UTR sequence does not contain any known functional 5’
UTR sequence pattern, nor any of sequence variants
create a new one.
Based on the BRCA2 5’ UTR sequences from four dif-
ferent species, RNAalifold software built consensus sec-
ondary structure (Figures 2, 3) with a minimum free en-
ergy of –98.63 kcal/mol (–50.63 kcal/mol from MFE
averaged over all sequences in the alignment plus –48.00
kcal/mol from covariance contributions). Figure 3 shows
conventional secondary structure drawing with conser-
vation annotation.
Folding of human wild type BRCA2 5’ UTR using
consensus structure as a constraint gave a secondary
structure with MFE of –73.60 kcal/mol (Figure 4a) and
that structure greatly resembles consensus one (Figure
3). Folding of BRCA2 5’ UTR with one of each sequence
variant with the same constraint gave secondary struc-
tures that ranged in MFE from –76.20 to –72.10 kcal/mol
(Figures 4b to 4n). Compared to wild type sequence, dif-
ferences in MFE ranged from +1.50 to –2.60 kcal/mol.
Most of the 5’ UTR sequence alterations (10 of 13) are
found near the 3’ end of 5’ UTR, what is in the vicinity of
the translation initiation site. All three nucleotide chan-
ges at position c.-26 disrupted conserved substructure
with three small loops and created one big loop with
smaller MFE. The same situation was with sequence
variant c.-12T>C (Figure 4l) but not c.-12T>G (Figure
4k). These four sequence variants most notably changed
consensus secondary structure. Variant c.-14T>C com-
pletely resembles wild type structure but has a lower (more
stable) MFE (Figure 4j). Sequence variant c.-123G>T is
the only alteration positioned more upstream from the
translation start site that changed consensus secondary
structure (Figure 4c).
DISCUSSION
Among nine different BRCA2 5’ UTR sequences,
only four had enough sequence identity and similarity
for building multiple sequence alignment, what is pre-
requisite for predicting consensus secondary structure. It
is interesting that mouse and rat, although not so evolu-
tionary distant from human, have completely different se-
quences of BRCA2 5’ UTR. That could also imply differ-
ences in regulation of BRCA2 expression. The same
situation is with mouse and human BRCA1 5’ UTR (36).
The amount of sequence variants found in BRCA2 5’
UTR is much higher than in BRCA1 5’ UTR (13 com-
pared to 4). Since genetic testing of BRCA1 and BRCA2
5’ and 3’ UTRs is not so commonly performed as for their
coding region, the reason for that discrepancy is not clear.
This could potentially imply two things: first, that the
role of BRCA2 5’ UTR in post-transcriptional regulation
of protein translation efficiency is not so important and
greater sequence variability is allowed; or second, that
more breast cancers could be connected with mutations
in BRCA2 5’ UTR. Unfortunately, it is not known for all
BRCA2 5’ UTR variants how they co-segregate with
breast/ovarian cancer and what is their penetrance.
Most of the 5’ UTR sequence alterations (10 of 13) are
found near the 3’ end of 5’ UTR, what is in the vicinity of
the translation initiation site. Our study confirmed find-
ing from Gochhait et al. (17) that substitution of G with
A at position –26 from the first AUG codon created sub-
structures with lower minimum free energy, thus less sta-
ble. They also showed that this c.-26G>A variant is
functional in a way so that the A allele increased the re-
porter gene expression by twice that of the wild type H al-
lele (17). As three another sequence variants c.-26G>C,
c.-26G>T and c.-12T>C in the same manner disturbed
consensus secondary structure near the translation initi-
ation site, they could also increase the efficiency of the
translation and thereby increase the expression of BRCA2.
This is in agreement with the work of Vega Laso and col-
leagues (37) and Kozak (38), who argued that the extent
of a hairpin negative effect on eukaryotic mRNA transla-
tion in vivo depends upon its stability and localization
within the molecule. Also, according to their findings, for
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–98.63 kcal/mol
Figure 3. Classical graphical representation of BRCA2 5’ UTR con-
sensus secondary structure with minimum free energy (MFE). Vari-
able positions are circled (one circle, consistent mutation; two circles,
compensatory mutation). The coloring scheme is the same as for Fig-
ure 2.
sequence variant c.-123G>T is less likely to be func-
tional because it is positioned closer to the 5’ end of 5’
UTR. All this findings suggested that this three BRCA2
5’ UTR sequence variants, c.-26G>C, c.-26G>T and
c.-12T>C, as the c.-26G>A variant, are suitable candi-
dates for further functional characterization and that
they could be potentially clinically significant.
In conclusion, as there is no more experimental vali-
dation of possible effects of human BRCA2 5’ UTR se-
quence variants, besides that for variant c.-26G>A, in
Period biol, Vol 112, No 4, 2010. 473
BRCA2 5’ UTR sequence variants P. Ozreti} et al.
–73.60 kcal/mol –73.60 kcal/mol –72.10 kcal/mol –73.30 kcal/mol
–72.50 kcal/mol –73.30 kcal/mol –73.30 kcal/mol –73.30 kcal/mol
–75.70 kcal/mol –76.20 kcal/mol –75.50 kcal/mol –73.30 kcal/mol
–75.80 kcal/mol –75.30 kcal/mol
c.-11C>T
c.-9T>C
c.-15A>C
c.-14T>C c.-12T>G c.-12T>C
c.-34T>C
c.-26G>A
c.-26G>T
c.-175C>T
c.-123G>T
c.-52A>G
c.-26G>C
Figure 4. Potential effect of each BRCA2 5’ UTR sequence variant on consensus secondary structure. For wild type and each sequence variant folding
into the structure with minimum free energy (MFE) was predicted using consensus secondary structure (Figure 2 and 3) as a constraint. Structure
colors encode base-pair probabilities.
silico analysis made the first step in that elucidation.
Computational screening for 5’ UTR sequence variants
with eventual structural and functional significance is a
valuable tool for narrowing a list of candidates for further
(much more laborious and expensive) experimental mo-
lecular characterization.
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